Get the full Stemora, Inc. company profile
Access contacts, investors, buying signals & more
Stemora, Inc. has raised $25K in funding from Tedco. The preclinical-stage biotechnology company is developing a one-step, disease-modifying regenerative therapy for osteoarthritis.
The therapy works by activating the body's own skeletal stem cells to regenerate native hyaline cartilage, targeting the root cause of osteoarthritis rather than just managing symptoms. Stemora holds an exclusive worldwide license from Stanford University and is pursuing an FDA 505(b)(2) regulatory pathway.
TEDCO Announces 2026 Concept Capital Pitch Competition Winner - citybiz TEDCO Announces 2026 Concept Capital Pitch Competition Winner | citybiz TEDCO , Maryland’s economic engine for technology companies, announced the winner for the Concept Capital Pitch Competition , Stemora .
The pitch competition gave these founders the chance to obtain an additional $25,000 at the 2026 Entrepreneur Expo. “Not every entrepreneur has access to friends-and-family funding, and that gap can keep promising ideas from moving forward,” said TEDCO CEO, Troy LeMaile-Stovall . “Concept Capital helps address that early-stage funding need. By hosting this competition for additional funding, we ar
Nums AI
Nums AI builds TFM (Tabular Foundation Model), a foundation model with one mission: predicting the world through numbers. Foundation models have transformed text and images, yet the tables that actually run a business have stayed untouched. TFM changes that. It turns the structured data at the heart of every enterprise into predictions. One model, pre-trained once, makes state-of-the-art results across commerce, healthcare, finance, manufacturing, and defense.
$1.5M Pre-seed
today
PathoSense
PathoSense is a spin-off from Ghent University and developed a complete sample-collection-to-diagnostic interpretation platform for infectious diseases in veterinary medicine using nanopore sequencing. Without prior knowledge, a full overview of all pathogens in a sample can be given. We are currently scaling this platform by setting up partnerships with veterinary diagnostic laboratories in Europe. Furthermore, PathoSense is an Oxford Nanopore Technologies Certified Services Provider and we offer fast and complete bacterial whole genome sequencing, microbiome analysis and viral whole genome sequencing. We are not just a sequencing provider but want to understand your question and help you in the best way possible to obtain biologically meaningful insights from your data.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  GPN Vaccines Australia | Unknown | $10.0M | today |
| 2 |  Tenet Diagnostics India | Unknown | $30.0M | today |
$500.0K Seed
today
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |  flipflow Spain | Unknown | $3.4M | today |
| 4 |  Archiboost AI United States | Unknown | $6.2M | today |
| 5 |  Biotts Poland | Unknown | $6.3M | today |
Tedco
VC
Reach Stemora, Inc.'s investors directly from your dashboard.
Start free trialThryv Therapeutics Inc.
Recently received
BionicM
Recently received
Nanostine
Recently received
